Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A government funding-status notice is now displayed on the page, and the page revision updated from v3.4.0 to v3.4.1, replacing the previous revision.
    Difference
    0.4%
    Check dated 2026-02-04T10:40:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Glossary visibility was added to the page, and a 'Last Update Submitted that Met QC Criteria' label is now displayed. The 'No FEAR Act Data' label is present and the revision version has been updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:33:12.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; this appears to be a small platform update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:29:44.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision note 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link as well as the previous 'Revision: v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:03:58.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Publications section wording updated to reflect automatic PubMed publications and a new Revision: v3.3.2 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:38.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removed the generic government funding and operating-status notice from the page footer, which previously informed users about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.